Report Detail

Pharma & Healthcare Global Bromhexine Market Insights and Forecast to 2026

  • RnM4170195
  • |
  • 27 August, 2020
  • |
  • Global
  • |
  • 154 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Bromhexine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bromhexine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Bromhexine market is segmented into
Oral
Injection

Segment by Application, the Bromhexine market is segmented into
Chronic Bronchitis
Asthma
Other

Regional and Country-level Analysis
The Bromhexine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bromhexine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bromhexine Market Share Analysis
Bromhexine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bromhexine business, the date to enter into the Bromhexine market, Bromhexine product introduction, recent developments, etc.

The major vendors covered:
Sanofi Aventis
Teva
Boehringer Ingelheim
Novartis
Mylan
Sanyo Chemical Laboratroy
Sandoz
LGM Pharma
GSK
Mayne Pharma
Sigma-Aldrich
Abbott
Shanghai Sine Tianping Pharmaceutical
Takeda
Shanghai Xudong Haipu Pharmaceutical
Jincheng Haisi Pharmaceutical
Shanxi Powerdone Pharmaceutical
Shanxi Powerdone Pharmaceutical
Wanbangde Pharmaceutical Group
Shijiazhuang No.4 Pharmaceutical
Ma'AnShan BBCA Pharmaceutical


1 Study Coverage

  • 1.1 Bromhexine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Bromhexine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Bromhexine Market Size Growth Rate by Type
    • 1.4.2 Oral
    • 1.4.3 Injection
  • 1.5 Market by Application
    • 1.5.1 Global Bromhexine Market Size Growth Rate by Application
    • 1.5.2 Chronic Bronchitis
    • 1.5.3 Asthma
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Bromhexine Market Size, Estimates and Forecasts
    • 2.1.1 Global Bromhexine Revenue 2015-2026
    • 2.1.2 Global Bromhexine Sales 2015-2026
  • 2.2 Global Bromhexine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Bromhexine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Bromhexine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Bromhexine Competitor Landscape by Players

  • 3.1 Bromhexine Sales by Manufacturers
    • 3.1.1 Bromhexine Sales by Manufacturers (2015-2020)
    • 3.1.2 Bromhexine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Bromhexine Revenue by Manufacturers
    • 3.2.1 Bromhexine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Bromhexine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Bromhexine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Bromhexine Revenue in 2019
    • 3.2.5 Global Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Bromhexine Price by Manufacturers
  • 3.4 Bromhexine Manufacturing Base Distribution, Product Types
    • 3.4.1 Bromhexine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Bromhexine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Bromhexine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Bromhexine Market Size by Type (2015-2020)
    • 4.1.1 Global Bromhexine Sales by Type (2015-2020)
    • 4.1.2 Global Bromhexine Revenue by Type (2015-2020)
    • 4.1.3 Bromhexine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Bromhexine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Bromhexine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Bromhexine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Bromhexine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Bromhexine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Bromhexine Market Size by Application (2015-2020)
    • 5.1.1 Global Bromhexine Sales by Application (2015-2020)
    • 5.1.2 Global Bromhexine Revenue by Application (2015-2020)
    • 5.1.3 Bromhexine Price by Application (2015-2020)
  • 5.2 Bromhexine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Bromhexine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Bromhexine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Bromhexine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Bromhexine by Country
    • 6.1.1 North America Bromhexine Sales by Country
    • 6.1.2 North America Bromhexine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Bromhexine Market Facts & Figures by Type
  • 6.3 North America Bromhexine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Bromhexine by Country
    • 7.1.1 Europe Bromhexine Sales by Country
    • 7.1.2 Europe Bromhexine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Bromhexine Market Facts & Figures by Type
  • 7.3 Europe Bromhexine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Bromhexine by Region
    • 8.1.1 Asia Pacific Bromhexine Sales by Region
    • 8.1.2 Asia Pacific Bromhexine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Bromhexine Market Facts & Figures by Type
  • 8.3 Asia Pacific Bromhexine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Bromhexine by Country
    • 9.1.1 Latin America Bromhexine Sales by Country
    • 9.1.2 Latin America Bromhexine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Bromhexine Market Facts & Figures by Type
  • 9.3 Central & South America Bromhexine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Bromhexine by Country
    • 10.1.1 Middle East and Africa Bromhexine Sales by Country
    • 10.1.2 Middle East and Africa Bromhexine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Bromhexine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Bromhexine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi Aventis
    • 11.1.1 Sanofi Aventis Corporation Information
    • 11.1.2 Sanofi Aventis Description and Business Overview
    • 11.1.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Aventis Bromhexine Products Offered
    • 11.1.5 Sanofi Aventis Related Developments
  • 11.2 Teva
    • 11.2.1 Teva Corporation Information
    • 11.2.2 Teva Description and Business Overview
    • 11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Teva Bromhexine Products Offered
    • 11.2.5 Teva Related Developments
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Corporation Information
    • 11.3.2 Boehringer Ingelheim Description and Business Overview
    • 11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Boehringer Ingelheim Bromhexine Products Offered
    • 11.3.5 Boehringer Ingelheim Related Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description and Business Overview
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Bromhexine Products Offered
    • 11.4.5 Novartis Related Developments
  • 11.5 Mylan
    • 11.5.1 Mylan Corporation Information
    • 11.5.2 Mylan Description and Business Overview
    • 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Bromhexine Products Offered
    • 11.5.5 Mylan Related Developments
  • 11.6 Sanyo Chemical Laboratroy
    • 11.6.1 Sanyo Chemical Laboratroy Corporation Information
    • 11.6.2 Sanyo Chemical Laboratroy Description and Business Overview
    • 11.6.3 Sanyo Chemical Laboratroy Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Sanyo Chemical Laboratroy Bromhexine Products Offered
    • 11.6.5 Sanyo Chemical Laboratroy Related Developments
  • 11.7 Sandoz
    • 11.7.1 Sandoz Corporation Information
    • 11.7.2 Sandoz Description and Business Overview
    • 11.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sandoz Bromhexine Products Offered
    • 11.7.5 Sandoz Related Developments
  • 11.8 LGM Pharma
    • 11.8.1 LGM Pharma Corporation Information
    • 11.8.2 LGM Pharma Description and Business Overview
    • 11.8.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 LGM Pharma Bromhexine Products Offered
    • 11.8.5 LGM Pharma Related Developments
  • 11.9 GSK
    • 11.9.1 GSK Corporation Information
    • 11.9.2 GSK Description and Business Overview
    • 11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 GSK Bromhexine Products Offered
    • 11.9.5 GSK Related Developments
  • 11.10 Mayne Pharma
    • 11.10.1 Mayne Pharma Corporation Information
    • 11.10.2 Mayne Pharma Description and Business Overview
    • 11.10.3 Mayne Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Mayne Pharma Bromhexine Products Offered
    • 11.10.5 Mayne Pharma Related Developments
  • 11.1 Sanofi Aventis
    • 11.1.1 Sanofi Aventis Corporation Information
    • 11.1.2 Sanofi Aventis Description and Business Overview
    • 11.1.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Aventis Bromhexine Products Offered
    • 11.1.5 Sanofi Aventis Related Developments
  • 11.12 Abbott
    • 11.12.1 Abbott Corporation Information
    • 11.12.2 Abbott Description and Business Overview
    • 11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Abbott Products Offered
    • 11.12.5 Abbott Related Developments
  • 11.13 Shanghai Sine Tianping Pharmaceutical
    • 11.13.1 Shanghai Sine Tianping Pharmaceutical Corporation Information
    • 11.13.2 Shanghai Sine Tianping Pharmaceutical Description and Business Overview
    • 11.13.3 Shanghai Sine Tianping Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Shanghai Sine Tianping Pharmaceutical Products Offered
    • 11.13.5 Shanghai Sine Tianping Pharmaceutical Related Developments
  • 11.14 Takeda
    • 11.14.1 Takeda Corporation Information
    • 11.14.2 Takeda Description and Business Overview
    • 11.14.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Takeda Products Offered
    • 11.14.5 Takeda Related Developments
  • 11.15 Shanghai Xudong Haipu Pharmaceutical
    • 11.15.1 Shanghai Xudong Haipu Pharmaceutical Corporation Information
    • 11.15.2 Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
    • 11.15.3 Shanghai Xudong Haipu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Shanghai Xudong Haipu Pharmaceutical Products Offered
    • 11.15.5 Shanghai Xudong Haipu Pharmaceutical Related Developments
  • 11.16 Jincheng Haisi Pharmaceutical
    • 11.16.1 Jincheng Haisi Pharmaceutical Corporation Information
    • 11.16.2 Jincheng Haisi Pharmaceutical Description and Business Overview
    • 11.16.3 Jincheng Haisi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Jincheng Haisi Pharmaceutical Products Offered
    • 11.16.5 Jincheng Haisi Pharmaceutical Related Developments
  • 11.17 Shanxi Powerdone Pharmaceutical
    • 11.17.1 Shanxi Powerdone Pharmaceutical Corporation Information
    • 11.17.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
    • 11.17.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Shanxi Powerdone Pharmaceutical Products Offered
    • 11.17.5 Shanxi Powerdone Pharmaceutical Related Developments
  • 11.18 Shanxi Powerdone Pharmaceutical
    • 11.18.1 Shanxi Powerdone Pharmaceutical Corporation Information
    • 11.18.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
    • 11.18.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Shanxi Powerdone Pharmaceutical Products Offered
    • 11.18.5 Shanxi Powerdone Pharmaceutical Related Developments
  • 11.19 Wanbangde Pharmaceutical Group
    • 11.19.1 Wanbangde Pharmaceutical Group Corporation Information
    • 11.19.2 Wanbangde Pharmaceutical Group Description and Business Overview
    • 11.19.3 Wanbangde Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Wanbangde Pharmaceutical Group Products Offered
    • 11.19.5 Wanbangde Pharmaceutical Group Related Developments
  • 11.20 Shijiazhuang No.4 Pharmaceutical
    • 11.20.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
    • 11.20.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
    • 11.20.3 Shijiazhuang No.4 Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Shijiazhuang No.4 Pharmaceutical Products Offered
    • 11.20.5 Shijiazhuang No.4 Pharmaceutical Related Developments
  • 11.21 Ma'AnShan BBCA Pharmaceutical
    • 11.21.1 Ma'AnShan BBCA Pharmaceutical Corporation Information
    • 11.21.2 Ma'AnShan BBCA Pharmaceutical Description and Business Overview
    • 11.21.3 Ma'AnShan BBCA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.21.4 Ma'AnShan BBCA Pharmaceutical Products Offered
    • 11.21.5 Ma'AnShan BBCA Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Bromhexine Market Estimates and Projections by Region
    • 12.1.1 Global Bromhexine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Bromhexine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Bromhexine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Bromhexine Sales Forecast (2021-2026)
    • 12.2.2 North America: Bromhexine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Bromhexine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Bromhexine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Bromhexine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Bromhexine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Bromhexine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Bromhexine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Bromhexine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Bromhexine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Bromhexine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Bromhexine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Bromhexine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Bromhexine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Bromhexine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Bromhexine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Bromhexine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Bromhexine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Bromhexine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Bromhexine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Bromhexine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Bromhexine. Industry analysis & Market Report on Bromhexine is a syndicated market report, published as Global Bromhexine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Bromhexine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,006.90
    4,510.35
    6,013.80
    3,611.40
    5,417.10
    7,222.80
    597,636.00
    896,454.00
    1,195,272.00
    328,887.00
    493,330.50
    657,774.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report